Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France

European Journal of Cancer

Volumn 58, Issue , 2016, Pages 90-96

  Penel, Nicolas ^a,b   Coindre, Jean Michel ^c   Bonvalot, Sylvie ^d,e   Italiano, Antoine ^c   Neuville, Agnès ^c   Le Cesne, Axel ^d   Terrier, Philippe ^d   Ray Coquard, Isabelle ^f   Ranchere Vince, Dominique ^f   Robin, Yves Marie ^a   Isambert, Nicolas ^g   Ferron, Gwennaël ^h   Duffaud, Florence ⁱ   Bertucci, François ^j   Rios, Maria ^k   Stoeckle, Eberhad ^c   Le Pechoux, Cécile ^d   Guillemet, Cécile ^l   Courreges, Jean Baptiste ^c   Blay, Jean Yves ^f  

^a CENTRE OSCAR LAMBRET   (France)

^b SIRIC OncoLille Consortium   (France)

^c INSTITUT BERGONIÉ   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e INSTITUT CURIE   (France)

^f CENTRE LÉON BÉRARD   (France)

^g CENTRE GEORGES FRANÇOIS LECLERC   (France)

^h Institut Universitaire du Cancer de Toulouse   (France)

ⁱ TIMONE HOSPITAL   (France)

^j INSTITUT PAOLI CALMETTES   (France)

^k CENTRE ALEXIS VAUTRIN   (France)

^l CENTRE HENRI BECQUEREL   (France)

more..

Author keywords

Desmoid tumours; Expert network; Key indicators of activity; Rare tumours; Reference centres

Indexed keywords

ADULT; ARTICLE; CANCER CENTER; CANCER INCIDENCE; CANCER THERAPY; DATA BASE; DESMOID TUMOR; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ETHICS; MUTATIONAL ANALYSIS; NATIONAL HEALTH ORGANIZATION; NEEDLE BIOPSY; PATHOLOGIST; PATIENT ADVOCACY; PATIENT REFERRAL; PRIORITY JOURNAL; TUMOR DIAGNOSIS; ADOLESCENT; AGED; CHILD; CLINICAL TRIAL; COOPERATION; DNA MUTATIONAL ANALYSIS; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; FACTUAL DATABASE; FIBROMATOSIS, AGGRESSIVE; GENETIC PREDISPOSITION; GENETICS; HEALTH CARE QUALITY; HEALTH CARE SURVEY; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; LARGE CORE NEEDLE BIOPSY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MUTATION; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PATIENT CARE; PHENOTYPE; PREDICTIVE VALUE; PROGRAM EVALUATION; STANDARDS; TIME FACTOR; TIME TO TREATMENT; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

BETA CATENIN; CTNNB1 PROTEIN, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BETA CATENIN; BIOMARKERS, TUMOR; BIOPSY, LARGE-CORE NEEDLE; CHILD; COOPERATIVE BEHAVIOR; DATABASES, FACTUAL; DELIVERY OF HEALTH CARE, INTEGRATED; DNA MUTATIONAL ANALYSIS; EARLY DETECTION OF CANCER; FEMALE; FIBROMATOSIS, AGGRESSIVE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HEALTH CARE SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; PATIENT CARE TEAM; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGRAM EVALUATION; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; REFERRAL AND CONSULTATION; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84960422441     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2016.02.008     Document Type: Article

References (20)

1. D.L. van Broekhoven, D.J. Grünhagen, M.A. den Bakker, T. van Dalen, and C. Verhoef Time trends in the incidence and treatment of extra-abdominal and abdominal aggressive fibromatosis: A population-based study Ann Surg Oncol 22 2015 2817 2823
2. A. Sinha, P.P. Tekkis, D.C. Gibbons, R.K. Phillips, and S.K. Clark Risk factors predicting desmoid occurrence in patients with familial adenomatous polyposis: A meta-analysis Colorectal Dis 13 2011 1222 1229
3. S. Schiessling, M. Kihm, P. Ganschow, G. Kadmon, M.W. Büchler, and M. Kadmon Desmoid tumour biology in patients with familial adenomatous polyposis coli Br J Surg 100 2013 694 703
4. S. Salas, A. Dufresne, B. Bui, J.Y. Blay, P. Terrier, D. Ranchere-Vince, and et al. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: A wait-and-see policy according to tumor presentation J Clin Oncol 29 2011 3553 3558
5. S. Le Guellec, I. Soubeyran, P. Rochaix, T. Filleron, A. Neuville, I. Hosein, and et al. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: A study of 260 desmoid tumors and 191 potential morphologic mimics Mod Pathol 25 2012 1551 1558
6. C. Colombo, R. Miceli, A.J. Lazar, F. Perrone, R.E. Pollock, A. Le Cesne, and et al. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study Cancer 119 2013 3696 3702
7. P. Rigaux, D. Lefebvre-Kuntz, N. Penel "SOS Desmoïde" Pain burden in desmoid tumor patients: A survey of the French Advocacy Group SOS Desmoid Bull Cancer 102 2015 213 216
8. C. Colombo, R. Miceli, C. Le Péchoux, E. Palassini, C. Honoré, S. Stacchiotti, and et al. Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients Eur J Cancer 51 2015 186 192
9. B. Kasper, C. Baumgarten, S. Bonvalot, R. Haas, F. Haller, P. Hohenberger, and et al. Management of sporadic desmoid-type fibromatosis: A European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative Eur J Cancer 51 2015 127 136
10. G. Branagan, and N. Davies Early impact of centralization of oesophageal cancer surgery services Br J Surg 91 2004 1630 1632
11. W. Hohenberger, S. Merkel, and P. Hermanek Volume and outcome in rectal cancer surgery: the importance of quality management Int J Colorectal Dis 28 2013 197 206
12. G.A. Gooiker, V.E. Lemmens, M.G. Besselink, P.N. Post, C.J. Van de Velde, R.A. Tollenaar, and et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival Br J Surg 101 2014 1000 1005
13. S. Suzumara, A. Ioka, T. Nakayama, H. Tsukuma, A. Oshima, and O. Ishikawa Hospital procedure volume and prognosis with respect to testicular cancer patients: A population-based study in Osaka, Japan Cancer Sci 99 2008 2260 2263
14. M.J. Harding, J. Paul, C.R. Gillis, and S.B. Kaye Management of malignant teratoma: does referral to a specialist unit matter? Lancet 341 1993 999 1002
15. R. Clasby, K. Tilling, M.A. Smith, and C.D. Fletcher Variable management of soft tissue sarcoma: regional audit with implications for specialist care Br J Surg 84 1997 1692 1696
16. C.R. Rossi, A. Vecchiato, G. Mastrangelo, M.C. Montesco, F. Russano, S. Mocellin, and et al. Adherence to treatment guidelines for primary sarcomas affect patient survival: A side study of the European CONnective TIssue CAncer NETwork (CONTICANET) Ann Oncol 24 2013 1685 1691
17. K. Ligier, C. Maynou, X. Leroy, Y.M. Robin, P. Martin, S. Clisant, and et al. Improvement of the initial management of sarcomas after dissemination of evidence-based guidelines depends on the primary sarcoma location: A population-based study BMC Cancer 15 2015 218
18. P. Gustafson, K.E. Dreinhöfer, and A. Rydholm Soft tissue sarcoma should be treated at a tumor center. A comparison of quality of surgery in 375 patients Acta Orthop Scand 65 1994 47 50
19. M.M. Sampo, M. Rönty, M. Tarkkanen, E.J. Tukiainen, T.O. Böhling, and C.P. Blomqvist Soft tissue sarcoma - a population-based, nationwide study with special emphasis on local control Acta Oncol 51 2012 706 712
20. I. Ray-Coquard, P. Thiesse, D. Ranchère-Vince, F. Chauvin, J.Y. Bobin, M.P. Sunyach, and et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas Ann Oncol 15 2004 307 315